Chimeric Therapeutics, a clinical-stage cell therapy company, has entered into a strategic manufacturing partnership with WuXi Advanced Therapies (WuXi ATU), a global contract testing and manufacturing organization (CTDMO).
The partnership initially focusses on Chimeric
